Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

I-Mab Biopharma Receives FDA IND Clearance for Proprietary CD73 Antibody TJD5

americanpharmaceuticalreviewJanuary 23, 2019

Tag: I-Mab Biopharma , FDA , TJD5 , CD73 antibody

PharmaSources Customer Service